368 related articles for article (PubMed ID: 33261128)
21. Unwinding the Wnt action of casein kinase 1.
Yim DG; Virshup DM
Cell Res; 2013 Jun; 23(6):737-8. PubMed ID: 23567556
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of structural and conformational properties of casein kinase-1 isoforms: insights from molecular dynamics and principal component analysis.
Singh SP; Gupta DK
J Theor Biol; 2015 Apr; 371():59-68. PubMed ID: 25665722
[TBL] [Abstract][Full Text] [Related]
23. Discovery of selective phosphatidylinositol 3-kinase inhibitors to treat hematological malignancies.
Zhu J; Hou T; Mao X
Drug Discov Today; 2015 Aug; 20(8):988-94. PubMed ID: 25857437
[TBL] [Abstract][Full Text] [Related]
24. Current status of phosphoinotiside-3 kinase inhibitors in blood cancers.
Shouse G; Danilova OV; Danilov AV
Curr Opin Oncol; 2022 Sep; 34(5):540-545. PubMed ID: 35855508
[TBL] [Abstract][Full Text] [Related]
25. Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis.
Schittek B; Sinnberg T
Mol Cancer; 2014 Oct; 13():231. PubMed ID: 25306547
[TBL] [Abstract][Full Text] [Related]
26. Targeting Wnt signaling pseudokinases in hematological cancers.
Karvonen H; Perttilä R; Niininen W; Barker H; Ungureanu D
Eur J Haematol; 2018 Oct; 101(4):457-465. PubMed ID: 29989208
[TBL] [Abstract][Full Text] [Related]
27. Negative regulation of Wnt signaling mediated by CK1-phosphorylated Dishevelled via Ror2.
Witte F; Bernatik O; Kirchner K; Masek J; Mahl A; Krejci P; Mundlos S; Schambony A; Bryja V; Stricker S
FASEB J; 2010 Jul; 24(7):2417-26. PubMed ID: 20215527
[TBL] [Abstract][Full Text] [Related]
28. Wnt Signaling in Hematological Malignancies.
Grainger S; Traver D; Willert K
Prog Mol Biol Transl Sci; 2018 Jan; 153():321-341. PubMed ID: 29389522
[TBL] [Abstract][Full Text] [Related]
29. Cardiomyocyte differentiation of pluripotent stem cells with SB203580 analogues correlates with Wnt pathway CK1 inhibition independent of p38 MAPK signaling.
Laco F; Low JL; Seow J; Woo TL; Zhong Q; Seayad J; Liu Z; Wei H; Reuveny S; Elliott DA; Chai CL; Oh SK
J Mol Cell Cardiol; 2015 Mar; 80():56-70. PubMed ID: 25528965
[TBL] [Abstract][Full Text] [Related]
30. The rise of apoptosis: targeting apoptosis in hematologic malignancies.
Valentin R; Grabow S; Davids MS
Blood; 2018 Sep; 132(12):1248-1264. PubMed ID: 30012635
[TBL] [Abstract][Full Text] [Related]
31. Small molecule modulators targeting protein kinase CK1 and CK2.
Qiao Y; Chen T; Yang H; Chen Y; Lin H; Qu W; Feng F; Liu W; Guo Q; Liu Z; Sun H
Eur J Med Chem; 2019 Nov; 181():111581. PubMed ID: 31400711
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening.
Cozza G; Gianoncelli A; Montopoli M; Caparrotta L; Venerando A; Meggio F; Pinna LA; Zagotto G; Moro S
Bioorg Med Chem Lett; 2008 Oct; 18(20):5672-5. PubMed ID: 18799313
[TBL] [Abstract][Full Text] [Related]
33. Dynamic conformational ensembles regulate casein kinase-1 isoforms: Insights from molecular dynamics and molecular docking studies.
Singh SP; Gupta DK
Comput Biol Chem; 2016 Apr; 61():39-46. PubMed ID: 26788877
[TBL] [Abstract][Full Text] [Related]
34. Casein kinases as potential therapeutic targets.
Cozza G; Pinna LA
Expert Opin Ther Targets; 2016; 20(3):319-40. PubMed ID: 26565594
[TBL] [Abstract][Full Text] [Related]
35. Isoform specific phosphorylation of p53 by protein kinase CK1.
Venerando A; Marin O; Cozza G; Bustos VH; Sarno S; Pinna LA
Cell Mol Life Sci; 2010 Apr; 67(7):1105-18. PubMed ID: 20041275
[TBL] [Abstract][Full Text] [Related]
36. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
[TBL] [Abstract][Full Text] [Related]
37. Casein kinase 1α-dependent feedback loop controls autophagy in RAS-driven cancers.
Cheong JK; Zhang F; Chua PJ; Bay BH; Thorburn A; Virshup DM
J Clin Invest; 2015 Apr; 125(4):1401-18. PubMed ID: 25798617
[TBL] [Abstract][Full Text] [Related]
38. Casein kinase I gamma subfamily. Molecular cloning, expression, and characterization of three mammalian isoforms and complementation of defects in the Saccharomyces cerevisiae YCK genes.
Zhai L; Graves PR; Robinson LC; Italiano M; Culbertson MR; Rowles J; Cobb MH; DePaoli-Roach AA; Roach PJ
J Biol Chem; 1995 May; 270(21):12717-24. PubMed ID: 7759525
[TBL] [Abstract][Full Text] [Related]
39. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
[TBL] [Abstract][Full Text] [Related]
40. Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival.
Varghese RT; Young S; Pham L; Liang Y; Pridham KJ; Guo S; Murphy S; Kelly DF; Sheng Z
Sci Rep; 2018 Sep; 8(1):13621. PubMed ID: 30206363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
